Tony Kalajian

Tony Kalajian

Net worth: 44 606 $ as of 2024-04-29

54 year
Health Technology
Consumer Services
Commercial Services

Profile

Tony Kalajian worked as a Senior Director-Finance at STAAR Surgical Co. from 2013 to 2016.
He then worked as the Chief Accounting Officer & Vice President at Lineage Cell Therapeutics, Inc. from 2016 to 2019.
Prior to that, he was a Senior Manager-Audit at PricewaterhouseCoopers LLP.
In 2019, he became the Chief Accounting Officer & Senior Vice President at OncoCyte Corp.
until 2020.
He also worked as the Chief Financial & Accounting Officer at Calidi Biotherapeutics, Inc. Mr. Kalajian received his undergraduate degree from The California State University and his MBA from USC Marshall School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-09-11 278,790 ( 0.78% ) 44 606 $ 2024-04-29

Former positions of Tony Kalajian

CompaniesPositionEnd
CALIDI BIOTHERAPEUTICS, INC. Director of Finance/CFO 2023-10-22
ONCOCYTE CORPORATION Comptroller/Controller/Auditor 2020-12-17
LINEAGE CELL THERAPEUTICS, INC. Comptroller/Controller/Auditor 2019-07-31
STAAR SURGICAL COMPANY Director of Finance/CFO 2016-03-31
Corporate Officer/Principal -
See the detail of Tony Kalajian's experience

Training of Tony Kalajian

The California State University Undergraduate Degree
USC Marshall School of Business Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tony Kalajian's experience

Connections

39

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
ONCOCYTE CORPORATION

Health Technology

LINEAGE CELL THERAPEUTICS, INC.

Health Technology

STAAR SURGICAL COMPANY

Health Technology

CALIDI BIOTHERAPEUTICS, INC.

Health Technology

Private companies1

Commercial Services

See company connections